靶向蛋白质组学识别南非黑人男性和女性血糖异常、β细胞功能及胰岛素敏感性的潜在生物标志物
本研究采用靶向蛋白质组学方法,在南非黑人中年队列(MASC)中识别与糖代谢异常(IGM)和2型糖尿病相关的循环蛋白,并在瑞典EpiHealth队列中验证。共发现73种与血糖异常相关的蛋白,其中34种在EpiHealth队列中得到验证,11种与胰岛素动态指标相关。IGFBP2与女性HOMA-IR降低相关(系数-0.35),TIMP4仅在女性中与胰岛素分泌和β细胞功能相关,而IGFBP2与胰岛素敏感性的正相关在男性中更强(系数0.38)。
要点
- 在MASC队列中识别出73种与血糖异常相关的蛋白,其中34种在EpiHealth队列中验证。
- IGFBP2与女性HOMA-IR降低相关(系数-0.35),与男性HOMA-IR降低相关(系数-0.09)。
- TIMP4仅在女性中与胰岛素分泌(系数0.05)和β细胞功能(系数0.06)相关,且不通过肥胖介导。
核心结论
- 验证了34种与2型糖尿病相关的蛋白,其中11种与2型糖尿病病理生理指标如外周胰岛素敏感性和β细胞功能相关。
- 研究强调了不同祖先、生活方式和社会人口学特征队列之间相似的生物标志物。
- 非洲特异性生物标志物需要在非洲队列中验证,以识别风险标志物并增加对非洲人群2型糖尿病病理生理学的理解。
研究设计与样本
- 横断面研究,纳入南非黑人中年队列(MASC)的男性380例和女性375例。
- 使用双能X线吸收法测定脂肪质量和内脏脂肪组织,采集空腹静脉血分析血糖、胰岛素、C肽及靶向蛋白质组学(184种预选蛋白)。
- 对无糖尿病患者进行口服葡萄糖耐量试验(OGTT),估算外周胰岛素敏感性(Matsuda指数)、HOMA-IR、基础胰岛素清除率、胰岛素分泌(C肽指数)和β细胞功能(处置指数)。
- 参与者分为糖耐量正常(NGT;n=546)、IGM(n=116)或2型糖尿病(n=93)。
- 在瑞典EpiHealth队列中验证与血糖异常相关的蛋白(NGT,n=1706;空腹血糖受损,n=550;2型糖尿病,n=210)。
主要发现
- 在MASC中识别出73种与血糖异常相关的蛋白,其中34种在EpiHealth队列中验证。
- 在验证的蛋白中,11种与多种胰岛素动态指标相关,与HOMA-IR相关的蛋白数量最多。
- 在性别特异性分析中,IGFBP2与女性HOMA-IR降低相关(系数-0.35;95% CI -0.44,-0.25),与男性HOMA-IR降低相关(系数-0.09;95% CI -0.15,-0.03)。
- TIMP4仅在女性中与胰岛素分泌升高相关(系数0.05;95% CI 0.001,0.11;交互作用P=0.025)和β细胞功能升高相关(系数0.06;95% CI 0.02,0.09;交互作用P=0.013)。
- 在男性中观察到IGFBP2与OGTT确定的胰岛素敏感性之间有更强的正相关(系数0.38;95% CI 0.27,0.49;交互作用P=0.004)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 非洲特异性生物标志物需要在非洲队列中验证,以识别风险标志物并增加对非洲人群2型糖尿病病理生理学的理解。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Using a targeted proteomics approach, we aimed to identify and validate circulating proteins associated with impaired glucose metabolism (IGM) and type 2 diabetes in a Black South African cohort. In addition, we assessed sex-specific associations between the validated proteins and pathophysiological pathways of type 2 diabetes. METHODS: This cross-sectional study included Black South African men (n=380) and women (n=375) who were part of the Middle-Aged Soweto Cohort (MASC). Dual-energy x-ray absorptiometry was used to determine fat mass and visceral adipose tissue, and fasting venous blood samples were collected for analysis of glucose, insulin and C-peptide and for targeted proteomics, measuring a total of 184 pre-selected protein biomarkers. An OGTT was performed on participants without diabetes, and peripheral insulin sensitivity (Matsuda index), HOMA-IR, basal insulin clearance, insulin secretion (C-peptide index) and beta cell function (disposition index) were estimated. Participants were classified as having normal glucose tolerance (NGT; n=546), IGM (n=116) or type 2 diabetes (n=93). Proteins associated with dysglycaemia (IGM or type 2 diabetes) in the MASC were validated in the Swedish EpiHealth cohort (NGT, n=1706; impaired fasting glucose, n=550; type 2 diabetes, n=210). RESULTS: We identified 73 proteins associated with dysglycaemia in the MASC, of which 34 were validated in the EpiHealth cohort. Among these validated proteins, 11 were associated with various measures of insulin dynamics, with the largest number of proteins being associated with HOMA-IR. In sex-specific analyses, IGF-binding protein 2 (IGFBP2) was associated with lower HOMA-IR in women (coefficient -0.35; 95% CI -0.44, -0.25) and men (coefficient -0.09; 95% CI -0.15, -0.03). Metalloproteinase inhibitor 4 (TIMP4) was associated with higher insulin secretion (coefficient 0.05; 95% CI 0.001, 0.11; p for interaction=0.025) and beta cell function (coefficient 0.06; 95% CI 0.02, 0.09; p for interaction=0.013) in women only. In contrast, a stronger positive association between IGFBP2 and insulin sensitivity determined using an OGTT (coefficient 0.38; 95% CI 0.27, 0.49) was observed in men (p for interaction=0.004). A posteriori analysis showed that the associations between TIMP4 and insulin dynamics were not mediated by adiposity. In contrast, most of the associations between IGFBP2 and insulin dynamics, except for insulin secretion, were mediated by either fat mass index or visceral adipose tissue in men and women. Fat mass index was the strongest mediator between IGFBP2 and insulin sensitivity (total effect mediated 40.7%; 95% CI 37.0, 43.6) and IGFBP2 and HOMA-IR (total effect mediated 39.1%; 95% CI 31.1, 43.5) in men. CONCLUSIONS/INTERPRETATION: We validated 34 proteins that were associated with type 2 diabetes, of which 11 were associated with measures of type 2 diabetes pathophysiology such as peripheral insulin sensitivity and beta cell function. This study highlights biomarkers that are similar between cohorts of different ancestry, with different lifestyles and sociodemographic profiles. The African-specific biomarkers identified require validation in African cohorts to identify risk markers and increase our understanding of the pathophysiology of type 2 diabetes in African populations.
引用
- Mendham AE, Micklesfield LK, Karpe F, et al. Targeted proteomics identifies potential biomarkers of dysglycaemia, beta cell function and insulin sensitivity in Black African men and women. Diabetologia. 2022. PMID: 36114877. doi:10.1007/s00125-022-05788-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。